Mixed T-lymphocyte chimerism after allogeneic hematopoietic transplantation is predictive for relapse of AML/MDS

Chimerism testing following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) represents a promising tool for predicting disease relapse, although its precise role in this setting remains unclear. We inves...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biol Blood Marrow Transplant
Autors principals: Lee, Hans C., Saliba, Rima M., Rondon, Gabriela, Chen, Julianne, Charafeddine, Yasmeen, Medeiros, L. Jeffrey, Alatrash, Gheath, Andersson, Borje S., Popat, Uday, Kebriaei, Partow, Ciurea, Stefan, Oran, Betul, Shpall, Elizabeth, Champlin, Richard
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4604040/
https://ncbi.nlm.nih.gov/pubmed/26183077
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2015.07.005
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars